Ebusco has announced a strategic partnership with Gotion, a company specialised in power battery technologies, building on their collaboration started in 2018. The partnership will focus on enhancing Ebusco's lightweight buses with Gotion's advanced battery tech, expanding into the Asian market, an
Ageas: More bidders for ESURE UK ASR: Completion of KNAB sale, starting extra SBB D'Ieteren: Holding financing more costly, 2024 guidance (excluding financing) reassures Ebusco: Released from obligation to deliver 76 buses PostNL: 3Q24 below, FY24 outlook down, mail weak, parcels stronger; CEO steps down Sif Group: Preview - getting ready for 2025 Staffing: US temp volume weaker in October, Aug/Sep revised down, NFP jobs miss
This morning, Ebusco provided an update on its upcoming rights issue and discussions with key suppliers. Still aiming to complete the EUR36m rights issue this month, Ebusco indicated it has received interest from a group of investors, including its larger shareholders, to support the transaction th
>Q3 update includes a turnaround plan whereas management churn continues - The company gave a short trading update where it provides details of the Turnaround plan that it intends to present at its general meeting of shareholders today. Key caveats include opting for an Original Equipment Design (OED) manufacturing model, in which buses are designed and engineered by the company, but are assembled by contract manufacturers, instead of inhouse production. As part of t...
This morning, Ebusco announced it has delivered 135 buses YTD (ie. 37 in Q3) and confirmed the initial elements of its turnaround plan into 2025, but still fell short of FY24 guidance and cancelled its CMD. Ebusco's main objective remains switching to contract manufacturing rather than an in-house
Acomo: Hot Chocolate. Azelis: 3Q24 not flawless, but organic growth is back. BE Semiconductor Industries: 3Q24 results, putting its money where its mouth is. Ebusco: Rigorous turnaround plan, but many liquidity related concerns; recommendation moves to Under Review. GBL: Looking to take vitamins. Kinepolis: Solid 3Q24 attendance, in line, confident in the movie outlook for 4Q24, 2025. Ontex: Guidance Stumble. Unilever: Momentum maintained. Vastned: End of the disposal program, wa...
Ebusco today announced that it has initiated legal proceedings against one customer after the cancellation of orders representing 59 buses (o/w 45 12m buses). Ebusco is seeking delivery of - and payment for - the 45 12m buses already produced (>EUR20m in our estimates). This follows cancellation
Ebusco has announced this morning that it intends to raise up to EUR36m through a rights offering. The announcement follows (i) the complete reorganisation of Ebusco's management team in 2024, with the nomination of Roald Dogge as COO in March, Erland Morelissen in July and Christian Schreyer as CE
>A rights issue intended as part of the “Turnaround Plan” - The company announced today that it intends to raise up to €36m of new equity through a rights issue as part of its turnaround plan and hence convened an extraordinary general meeting of shareholders on 24th October 2024. The company also indicated that existing shareholders will have the opportunity to buy additional shares through exercising their rights and maintain their ownership percentage in the compan...
Last Friday, Ebusco's Board announced it had appointed Christian Schreyer as the new CEO, effective from 2nd September, replacing co-CEOs Peter Bijvelds and Michiel Peters as part of a broader turnaround plan. According to the press release, this plan emphasises the need for a single CEO with a gen
>Christian Schreyer appointed as sole new CEO, Founder/co-CEO steps down - On Friday evening post market close, the company announced that its founder and co-CEO, Peter Bijvelds and other co-CEO Michiel Peters will step down as per 2nd September 2024. As part of the previously announced Turnaround Plan, the executive team decided that the company required a single CEO (instead of co-CEO’s), hence Christian Schreyer is to be the CEO as per 2nd September 2024. The exits...
>An abominable H1 masked a bigger problem: Ebusco’s falling orderbook - Ebusco reported H1 sales figure of €38m which was 56% below our estimate and down approx. 9% on a year on year (YoY) basis. With gross margins at negative (€12m), EBITDA loss deepened to (€60.7m) against (€43.5m) a year ago. The company indicated that it will need extra funding for which it is in discussions and intends to implement a Turnaround Plan (Plan). Not surprisingly, the orderbook keeps ...
The Stoxx 600 gained just 1.1% in July after shedding 1.3% in June, driven by the SMI (+2.5%) and the Footsie 100 (+2.7%). With business sentiment indicators continuing to weaken, defensive stocks outperformed cyclicals in July, and many healthcare stocks were among the best performers of the Stoxx 600. Long-term interest rates have fallen sharply (probably too much), but this has not benefited tech and luxury goods stocks, penalised by their disappointing results publications. - ...
Le Stoxx 600 ne progresse que de 1,1% en juillet après sa baisse de 1,3% en juin, tiré par le SMI (+2,5%) et le Footsie 100 (+2,7%). Avec la poursuite du fléchissement des indicateurs de climat des affaires, les défensives ont surperformé les cycliques en juillet, et de nombreuses valeurs Santé sont présentes parmi les meilleures performances du Stoxx 600. Les taux d’intérêt longs ont nettement reflué (sans doute trop) sans que cela profite aux valeurs de la Tech ou du Luxe qui ont s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.